Fotemustine

Unknown Manufacturer

Fotemustine is an alkylating agent used in the treatment of metastatic melanoma.

Generate AI report

Overview

Fotemustine is an alkylating agent used in the treatment of metastatic melanoma.

Indications

原发性脑内肿瘤和播散性恶性黑色素瘤（包括脑内部位）。

Associated Conditions

1 associated conditions

Metastatic Melanoma

Technical identifiers

Chemical Formula: C₉H₁₉ClN₃O₅P
CAS Number: 92118-27-9
UNII ID: GQ7JL9P5I2

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

An anticancer sustained release injection carrying tumor drug resistance reversal agent and reversal agent synergist
CN 1875929 AApplicant: JINAN KANGQUAN PHARMACEUTICALPriority: 2006
CN
A compound sustained release anticancer agent containing angiogenesis inhibitor
CN 1875932 AApplicant: JINAN KANGQUAN PHARMACEUTICALPriority: 2006
CN
Compound sustained-released injection containing marimastat as neovascularization inhibitor
CN 101336911 AApplicant: JINAN KANGQUAN MEDICINE SCIENCPriority: 2006
CN
Compound sustained release injection containing newborn blood vessel inhibitor marimastat
CN 101224188 AApplicant: JINAN KANGQUAN MEDICINE SCIENCPriority: 2006
CN
Sustained release injection containing newborn blood vessel inhibitor
CN 101224189 AApplicant: JINAN KANGQUAN MEDICINE SCIENCPriority: 2006
CN
Compound sustained release injection containing newborn blood vessel inhibitor
CN 101224191 AApplicant: JINAN KANGQUAN MEDICINE SCIENCPriority: 2006
CN
Compound sustained release injection containing newborn blood vessel inhibitor fumagillin
CN 101224190 AApplicant: JINAN KANGQUAN MEDICINE SCIENCPriority: 2006
CN
Injection containing newborn blood vessel inhibitor
CN 101224192 AApplicant: JINAN KANGQUAN MEDICINE SCIENCPriority: 2006
CN
Compound sustained release injection containing newborn blood vessel inhibitor and cytotoxic drugs
CN 101224193 AApplicant: JINAN KANGQUAN MEDICINE SCIENCPriority: 2006
CN
Compound sustained-released injection containing neonatal blood vessel restraining agent
- CN 101305991 A
  Applicant: JINAN KANGQUAN PHARMACEUTICALPriority: 2006
  CN
- CN 101305992 A
  Applicant: JINAN KANGQUAN PHARMACEUTICALPriority: 2006
  CN

Drugs

Fotemustine

Overview

Indications

Associated Conditions

Patents

Compound sustained-released injection containing neonatal blood vessel restraining agent